|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Pharm Exec's Emerging Pharma Leaders 2018about 7 years ago
Choosing the Right Track: Pharma & Healthcare MBAsabout 7 years ago
Getting Where You Need to Goabout 7 years ago
Vienna’s Vision on Health Regulation in Europeabout 7 years ago
FDA Launches Major Push for New Antimicrobialsabout 7 years ago
Medical Affairs’ Search for MeaningNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Patients Avoid Care as Healthcare Costs Rise: Report
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
